Mindray Medical released its performance for the first three quarters, with a net profit attributable to the parent company of 7.57 billion yuan, a decrease of 28.83%

Mindray released its Q3 2025 report, with operating revenue for the first three quarters at 25.834 billion yuan, a year-on-year decrease of 12.38%; net profit attributable to the parent company was 7.57 billion yuan, a year-on-year decline of 28.83%; net profit excluding non-recurring gains and losses was 7.463 billion yuan, a year-on-year decrease of 28.50%; basic earnings per share were 6.2481 yuan